Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Invasive Breast Cancer
Interventions: OTHER: Eucerin|OTHER: Mometasone Furoate 0.1%
Sponsor: Memorial Sloan Kettering Cancer Center